This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leu, Y.-W. Articles by Huang, T. H.-M. Search for Related Content PubMed PubMed Citation Articles by Leu, Y.-W. Articles by Huang, T. H.-M.

Double RNA Interference of DNMT3b and DNMT1 Enhances DNA Demethylation and Gene Reactivation¹

Division of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210 [Y-W. L., S. H. W., J. C. L., P. S. Y., T. H-M. H.], and Department of Pathology and Anatomical Sciences, Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, Missouri 65203 [F. R., H. S.]

Small interfering RNAs (siRNAs) are newly identified molecules shown to silence genes via targeted mRNA degradation. In this study, we used specific siRNAs as a tool to probe the relationship between two DNA methyltransferase genes, DNMT3b and DNMT1, in the maintenance of DNA methylation patterns in the genome. Levels of DNMT3b or DNMT1 mRNAs and proteins were markedly decreased (up to 80%) on transfecting these siRNAs into the ovarian cancer cell line CP70. The resulting RNA interference showed differential effects on DNA demethylation and gene reactivation in the treated cells. The DNMT1 siRNA treatment led to a partial removal of DNA methylation from three inactive promoter CpG islands, TWIST, RASSF1A, and HIN-1, and restored the expression of these genes. This epigenetic alteration appeared less effective in cells transfected with DNMT3b siRNA. However, the combined treatment of DNMT3b and DNMT1 siRNAs greatly enhanced this demethylation effect, producing 7–15-fold increases in their expression. We also used a microarray approach to examine this RNA interference on 8640 CpG island loci in CP70 cells. The combined siRNA treatment had a greater demethylation effect on 241 methylated loci and selected repetitive sequences than that of the single treatment. Our data thus suggest that whereas DNMT1 plays a key role in methylation maintenance, DNMT3b may act as an accessory to support the function in CP70 cells. This study also shows that siRNA is a powerful tool for interrogating the mechanisms of DNA methylation in normal and pathological genomes.

This article has been cited by other articles:

				F. Spada, A. Haemmer, D. Kuch, U. Rothbauer, L. Schermelleh, E. Kremmer, T. Carell, G. Langst, and H. Leonhardt DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells J. Cell Biol., February 26, 2007; 176(5): 565 - 571. [Abstract] [Full Text] [PDF]

				D. Wu, Q. C.-K. Cheung, L. Wen, and J. Li A Growth-Maturation System That Enhances the Meiotic and Developmental Competence of Porcine Oocytes Isolated from Small Follicles Biol Reprod, October 1, 2006; 75(4): 547 - 554. [Abstract] [Full Text] [PDF]

				G. Egger, S. Jeong, S. G. Escobar, C. C. Cortez, T. W. H. Li, Y. Saito, C. B. Yoo, P. A. Jones, and G. Liang Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival PNAS, September 19, 2006; 103(38): 14080 - 14085. [Abstract] [Full Text] [PDF]

				J. Wang, G. Walsh, D. D. Liu, J. J. Lee, and L. Mao Expression of {Delta}DNMT3B Variants and Its Association with Promoter Methylation of p16 and RASSF1A in Primary Non-Small Cell Lung Cancer. Cancer Res., September 1, 2006; 66(17): 8361 - 8366. [Abstract] [Full Text] [PDF]

				A. Loriot, E. De Plaen, T. Boon, and C. De Smet Transient Down-regulation of DNMT1 Methyltransferase Leads to Activation and Stable Hypomethylation of MAGE-A1 in Melanoma Cells J. Biol. Chem., April 14, 2006; 281(15): 10118 - 10126. [Abstract] [Full Text] [PDF]

				A. H. Ting, K.-w. Jair, K. E. Schuebel, and S. B. Baylin Differential Requirement for DNA Methyltransferase 1 in Maintaining Human Cancer Cell Gene Promoter Hypermethylation Cancer Res., January 15, 2006; 66(2): 729 - 735. [Abstract] [Full Text] [PDF]

				P. W. Laird Cancer epigenetics Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R65 - R76. [Abstract] [Full Text] [PDF]

				J. Sung, J. Turner, S. McCarthy, S. Enkemann, C. G. Li, P. Yan, T. Huang, and T. J. Yeatman Oncogene regulation of tumor suppressor genes in tumorigenesis Carcinogenesis, February 1, 2005; 26(2): 487 - 494. [Abstract] [Full Text] [PDF]

				L. R. Vasques, R. Stabellini, F. Xue, X. C. Tian, M. Soukoyan, and L. V. Pereira XIST Repression in the Absence of DNMT1 and DNMT3B DNA Res, January 1, 2005; 12(5): 373 - 378. [Abstract] [Full Text] [PDF]

				V. Gorbunova, A. Seluanov, D. Mittelman, and J. H. Wilson Genome-wide demethylation destabilizes CTG{middle dot}CAG trinucleotide repeats in mammalian cells Hum. Mol. Genet., December 1, 2004; 13(23): 2979 - 2989. [Abstract] [Full Text] [PDF]

				Z. Yu and B. C. Kone Hypermethylation of the Inducible Nitric-oxide Synthase Gene Promoter Inhibits Its Transcription J. Biol. Chem., November 5, 2004; 279(45): 46954 - 46961. [Abstract] [Full Text] [PDF]